申请人:PFIZER LIMITED
公开号:US20150250785A1
公开(公告)日:2015-09-10
The present invention relates to compounds of Formula (IA) and (IB)
and their pharmaceutically acceptable salts, wherein the substituents are as described herein, and their use in medicine, in particular as Trk antagonists.
本发明涉及公式(IA)和(IB)化合物及其药学上可接受的盐,其中取代基如本文所述,并且它们在医学上的应用,特别是作为Trk拮抗剂。